An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.

NCT ID: NCT00750880

Last Updated: 2015-07-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1681 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2011-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open-label, single arm study will investigate the safety, tolerability and efficacy of tocilizumab monotherapy, or combination therapy with non-biologic disease modifying antirheumatic drugs (DMARDs), in patients with severe active RA. Patients will receive tocilizumab 8mg/kg iv as a 60 minute infusion every 4 weeks for a total of 6 infusions. The anticipated time on study treatment is 3-12 months, and the target sample size is \>500 individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

tocilizumab [RoActemra/Actemra]

Intervention Type DRUG

8mg/kg iv (60 minute infusion)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tocilizumab [RoActemra/Actemra]

8mg/kg iv (60 minute infusion)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male and non-pregnant or nursing female patients \>=18 years of age;
* body weight \<=150kg;
* moderate to severe active RA (DAS28 \>=3.2) of \>=6 months duration;
* on \>=1 non-biologic DMARDs at a stable dose for a period of \>= 8 weeks prior to start of treatment;
* inadequate clinical response to a stable dose of non-biologic DMARD or anti-TNF therapy;
* if receiving oral corticosteroids, the dose must have been stable for at least 25 of 28 days prior to start of treatment.

Exclusion Criteria

* major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months following enrollment;
* rheumatic autoimmune disease other than RA;
* prior history of, or current inflammatory joint disease other than RA;
* functional class IV as defined by the ACR Classification of Functional Status in RA.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Canberra, Australian Capital Territory, Australia

Site Status

Coffs Harbour, New South Wales, Australia

Site Status

Kogarah, New South Wales, Australia

Site Status

Parramatta Park, New South Wales, Australia

Site Status

Adelaide, South Australia, Australia

Site Status

Fitzroy, Victoria, Australia

Site Status

Geelong, Victoria, Australia

Site Status

Melbourne, Victoria, Australia

Site Status

Graz, , Austria

Site Status

Graz-Eggenberg, , Austria

Site Status

Innsbruck, , Austria

Site Status

Linz, , Austria

Site Status

Salzburg, , Austria

Site Status

Stockerau, , Austria

Site Status

Vienna, , Austria

Site Status

Vienna, , Austria

Site Status

Vienna, , Austria

Site Status

Aalst, , Belgium

Site Status

Brussels, , Belgium

Site Status

Brussels, , Belgium

Site Status

Brussels, , Belgium

Site Status

Brussels, , Belgium

Site Status

Edegem, , Belgium

Site Status

Ghent, , Belgium

Site Status

Hasselt, , Belgium

Site Status

Heusy, , Belgium

Site Status

Leuven, , Belgium

Site Status

Liège, , Belgium

Site Status

Merksem, , Belgium

Site Status

Montignies S/ Sambre, , Belgium

Site Status

Westmalle, , Belgium

Site Status

Edmonton, Alberta, Canada

Site Status

Lethbridge, Alberta, Canada

Site Status

Kelowna, British Columbia, Canada

Site Status

Nanaimo, British Columbia, Canada

Site Status

Vancouver, British Columbia, Canada

Site Status

Vancouver, British Columbia, Canada

Site Status

Quispamsis, New Brunswick, Canada

Site Status

St. John's, Newfoundland and Labrador, Canada

Site Status

Hamilton, Ontario, Canada

Site Status

Ottawa, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

Windsor, Ontario, Canada

Site Status

Laval, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Québec, Quebec, Canada

Site Status

Rimouski, Quebec, Canada

Site Status

Saint-Eustache, Quebec, Canada

Site Status

Sherbrooke, Quebec, Canada

Site Status

Trois-Rivières, Quebec, Canada

Site Status

Saskatoon, Saskatchewan, Canada

Site Status

Bruntál, , Czechia

Site Status

Ostrava, , Czechia

Site Status

Prague, , Czechia

Site Status

Sokolov, , Czechia

Site Status

Uherské Hradiště, , Czechia

Site Status

Zlín, , Czechia

Site Status

Aarhus, , Denmark

Site Status

Copenhagen, , Denmark

Site Status

Copenhagen, , Denmark

Site Status

Esbjerg, , Denmark

Site Status

Hjørring, , Denmark

Site Status

Silkeborg, , Denmark

Site Status

Helsinki, , Finland

Site Status

Jyväskylä, , Finland

Site Status

Turku, , Finland

Site Status

Argenteuil, , France

Site Status

Aulnay-sous-Bois, , France

Site Status

Belfort, , France

Site Status

Bobigny, , France

Site Status

Bourg-en-Bresse, , France

Site Status

Caen, , France

Site Status

Cahors, , France

Site Status

Colmar, , France

Site Status

Corbeil-Essonnes, , France

Site Status

Dijon, , France

Site Status

La Rochelle, , France

Site Status

Liévin, , France

Site Status

Lomme, , France

Site Status

Lyon, , France

Site Status

Lyon, , France

Site Status

Marseille, , France

Site Status

Montivilliers, , France

Site Status

Montpellier, , France

Site Status

Mulhouse, , France

Site Status

Paris, , France

Site Status

Paris, , France

Site Status

Pau, , France

Site Status

Poitiers, , France

Site Status

Reims, , France

Site Status

Roubaix, , France

Site Status

Saint-Brieuc, , France

Site Status

Strasbourg, , France

Site Status

Toulouse, , France

Site Status

Valence, , France

Site Status

Valenciennes, , France

Site Status

Berlin, , Germany

Site Status

Bielefeld, , Germany

Site Status

Freiburg im Breisgau, , Germany

Site Status

Greifswald, , Germany

Site Status

Hamburg, , Germany

Site Status

Jena, , Germany

Site Status

Kiel, , Germany

Site Status

Rostock, , Germany

Site Status

Saarbrücken, , Germany

Site Status

Wuppertal, , Germany

Site Status

Würzburg, , Germany

Site Status

Athens, , Greece

Site Status

Heraklion, , Greece

Site Status

Ioannina, , Greece

Site Status

Pátrai, , Greece

Site Status

Thessaloniki, , Greece

Site Status

Thessaloniki, , Greece

Site Status

Thessaloniki, , Greece

Site Status

Thessaloniki, , Greece

Site Status

Budapest, , Hungary

Site Status

Eger, , Hungary

Site Status

Gyula, , Hungary

Site Status

Szeged, , Hungary

Site Status

Veszprém, , Hungary

Site Status

Bangalore, , India

Site Status

Chennai, , India

Site Status

Hyderabad, , India

Site Status

Jaipur, , India

Site Status

Kolkata, , India

Site Status

Kolkata, , India

Site Status

Ludhiana, , India

Site Status

Mumbai, , India

Site Status

New Delhi, , India

Site Status

Pune, , India

Site Status

Co Leitrim, , Ireland

Site Status

Cork, , Ireland

Site Status

Dublin, , Ireland

Site Status

Dublin, , Ireland

Site Status

Dublin, , Ireland

Site Status

Dublin, , Ireland

Site Status

Galway, , Ireland

Site Status

Limerick, , Ireland

Site Status

Waterford, , Ireland

Site Status

Arenzano, , Italy

Site Status

Legnano, , Italy

Site Status

Milan, , Italy

Site Status

Milan, , Italy

Site Status

Milan, , Italy

Site Status

Modena, , Italy

Site Status

Monserrato, , Italy

Site Status

Novara, , Italy

Site Status

Palermo, , Italy

Site Status

Pescara, , Italy

Site Status

Potenza, , Italy

Site Status

Roma, , Italy

Site Status

Roma, , Italy

Site Status

Siena, , Italy

Site Status

Varese, , Italy

Site Status

Luxembourg, , Luxembourg

Site Status

's-Hertogenbosch, , Netherlands

Site Status

Alkmaar, , Netherlands

Site Status

Amsterdam, , Netherlands

Site Status

Apeldoorn, , Netherlands

Site Status

Arnhem, , Netherlands

Site Status

Bergen op Zoom, , Netherlands

Site Status

Den Helder, , Netherlands

Site Status

Enschede, , Netherlands

Site Status

Flushing, , Netherlands

Site Status

Gorinchem, , Netherlands

Site Status

Gouda, , Netherlands

Site Status

Heerlen, , Netherlands

Site Status

Hilversum, , Netherlands

Site Status

Leeuwarden, , Netherlands

Site Status

Leidschendam, , Netherlands

Site Status

Nieuwegein, , Netherlands

Site Status

Nijmegen, , Netherlands

Site Status

Roosendaal, , Netherlands

Site Status

Rotterdam, , Netherlands

Site Status

Rotterdam, , Netherlands

Site Status

Schiedam, , Netherlands

Site Status

Spijkenisse, , Netherlands

Site Status

The Hague, , Netherlands

Site Status

The Hague, , Netherlands

Site Status

Krakow, , Poland

Site Status

Poznan, , Poland

Site Status

Wroclaw, , Poland

Site Status

Almada, , Portugal

Site Status

Coimbra, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Porto, , Portugal

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Cluj-Napoca, , Romania

Site Status

Jeddah, , Saudi Arabia

Site Status

Jeddah, , Saudi Arabia

Site Status

Jeddah, , Saudi Arabia

Site Status

Alicante, Alicante, Spain

Site Status

Elche, Alicante, Spain

Site Status

Elda, Alicante, Spain

Site Status

Almería, Almeria, Spain

Site Status

Avilés, Avila, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Barcelona, Barcelona, Spain

Site Status

Sabadell, Barcelona, Spain

Site Status

Terrassa, Barcelona, Spain

Site Status

Vic, Barcelona, Spain

Site Status

Cáceres, Caceres, Spain

Site Status

Cadiz, Cadiz, Spain

Site Status

Jerez de la Frontera, Cadiz, Spain

Site Status

Córdoba, Cordoba, Spain

Site Status

Granada, Granada, Spain

Site Status

Huesca, Huesca, Spain

Site Status

A Coruña, La Coruña, Spain

Site Status

Las Palmas de Gran Canaria, Las Palmas, Spain

Site Status

León, Leon, Spain

Site Status

Ponferrada, Leon, Spain

Site Status

Lugo, Lugo, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Madrid, Madrid, Spain

Site Status

Málaga, Malaga, Spain

Site Status

Murcia, Murcia, Spain

Site Status

Ourense, Orense, Spain

Site Status

Salamanca, Salamanca, Spain

Site Status

Seville, Sevilla, Spain

Site Status

San Cristóbal de La Laguna, Tenerife, Spain

Site Status

Santa Cruz de Tenerife, Tenerife, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Valencia, Valencia, Spain

Site Status

Zaragoza, Zaragoza, Spain

Site Status

Falun, , Sweden

Site Status

Huddinge, , Sweden

Site Status

Karlstad, , Sweden

Site Status

Linköping, , Sweden

Site Status

Malmo, , Sweden

Site Status

Skövde, , Sweden

Site Status

Stockholm, , Sweden

Site Status

Uppsala, , Sweden

Site Status

Västerås, , Sweden

Site Status

Aarau, , Switzerland

Site Status

Basel, , Switzerland

Site Status

Fribourg, , Switzerland

Site Status

Geneva, , Switzerland

Site Status

Lucerne, , Switzerland

Site Status

Sankt Gallen, , Switzerland

Site Status

Zurich, , Switzerland

Site Status

Ankara, , Turkey (Türkiye)

Site Status

Istanbul, , Turkey (Türkiye)

Site Status

Barnsley, , United Kingdom

Site Status

Basingstoke, , United Kingdom

Site Status

Bournemouth, , United Kingdom

Site Status

Brighton, , United Kingdom

Site Status

Burton-on-Trent, , United Kingdom

Site Status

Bury Saint Edmonds, , United Kingdom

Site Status

Cambridge, , United Kingdom

Site Status

Cardiff, , United Kingdom

Site Status

Chelmsford, , United Kingdom

Site Status

Dudley, , United Kingdom

Site Status

Dundee, , United Kingdom

Site Status

Eastbourne, , United Kingdom

Site Status

Gillingham, , United Kingdom

Site Status

Harrogate, , United Kingdom

Site Status

Huddersfield, , United Kingdom

Site Status

Ipswich, , United Kingdom

Site Status

Liverpool, , United Kingdom

Site Status

Llantrisant, , United Kingdom

Site Status

London, , United Kingdom

Site Status

Londonderry, , United Kingdom

Site Status

Maidstone, , United Kingdom

Site Status

Metropolitan Borough of Wirral, , United Kingdom

Site Status

Middlesbrough, , United Kingdom

Site Status

Newcastle upon Tyne, , United Kingdom

Site Status

Nottingham, , United Kingdom

Site Status

Reading, , United Kingdom

Site Status

Salford, , United Kingdom

Site Status

Sheffield, , United Kingdom

Site Status

Southport, , United Kingdom

Site Status

Swindon, , United Kingdom

Site Status

Torquay, , United Kingdom

Site Status

Westcliffe-on-sea, , United Kingdom

Site Status

Worthing, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Austria Belgium Canada Czechia Denmark Finland France Germany Greece Hungary India Ireland Italy Luxembourg Netherlands Poland Portugal Romania Saudi Arabia Spain Sweden Switzerland Turkey (Türkiye) United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008-000587-17

Identifier Type: -

Identifier Source: secondary_id

MA21573

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.